Literature DB >> 25650242

Synthesis and characterization of an octaarginine functionalized graphene oxide nano-carrier for gene delivery applications.

Rana Imani1, Shahriar Hojjati Emami, Shahab Faghihi.   

Abstract

The success of gene therapy is largely dependent on the development of a gene carrier. Recently cell-penetrating peptides (CPPs) have been employed for enhancing the gene and drug delivery efficacy of nano-particles. The feasibility of octaarginine (R8) functionalized graphene oxide (GO) as a novel nano-carrier for gene delivery is investigated. A DNA plasmid expressing enhanced green fluorescent protein (pEGFP) is used as a model gene to study the R8-GO transfection ability into mammalian cells. R8 peptide is conjugated in different ratios (0.1-1.5 μmol per mg of GO) to carboxylated graphene oxide by a two step amidation process. The process of peptide conjugation is analyzed by Fourier transform infrared (FTIR), atomic force microscopy (AFM), UV-vis spectroscopy and X-ray diffraction (XRD). In order to obtain the highest transfection of pEGFP into the cells, the amount of peptide bound to GO is optimized which is evidenced by dynamic light scattering (DLS), zeta potential, TNBS and gel retardation assays. The cytotoxicity of R8-functionalized GO is also tested by MTT assay. The results confirm the successful attachment of R8 peptide to GO. The AFM and XRD results show a significant increase in the thickness of nano graphene oxide sheets (NGOS) from 0.8 to 2-7 nm as well as an increase in the GO interlying space after the R8-functionalization process. A reduction in nano-carrier stability in both aqueous solution and cell culture media is observed when the amount of peptide is increased to more than 1 μmol mg(-1). Gel electrophoresis analysis shows the highest DNA loading on the peptide functionalized GO at the ratios of 0.5 and 1 μmol mg(-1). As a result, the conjugated peptide sample with a peptide molar ratio of 1 μmol per mg of GO shows the highest conjugational efficiency and EGFP gene expression along with improved dispersibility and biocompatibility. Overall, the findings reveal the importance of peptide density on the surface of NGOS in order to obtain the most efficient cell transfection. It is concluded that the R8-conjugated GO could be a promising nano-carrier for gene delivery with relevance in biotechnology therapeutics and clinical applications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25650242     DOI: 10.1039/c4cp04301d

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  14 in total

1.  Electrophoretic deposition of graphene oxide reinforced chitosan-hydroxyapatite nanocomposite coatings on Ti substrate.

Authors:  Y Y Shi; M Li; Q Liu; Z J Jia; X C Xu; Y Cheng; Y F Zheng
Journal:  J Mater Sci Mater Med       Date:  2016-01-12       Impact factor: 3.896

Review 2.  Graphene materials as 2D non-viral gene transfer vector platforms.

Authors:  M Vincent; I de Lázaro; K Kostarelos
Journal:  Gene Ther       Date:  2016-11-22       Impact factor: 5.250

3.  Nanographene oxide-methylene blue as phototherapies platform for breast tumor ablation and metastasis prevention in a syngeneic orthotopic murine model.

Authors:  Mayara Simonelly Costa Dos Santos; Ana Luisa Gouvêa; Ludmilla David de Moura; Leonardo Giordano Paterno; Paulo Eduardo Narcizo de Souza; Ana Paula Bastos; Emanuel Adelino Medeiros Damasceno; Fabiane Hiratsuka Veiga-Souza; Ricardo Bentes de Azevedo; Sônia Nair Báo
Journal:  J Nanobiotechnology       Date:  2018-01-30       Impact factor: 10.435

Review 4.  Graphene and graphene-based materials in axonal repair of spinal cord injury.

Authors:  Shi-Xin Wang; Yu-Bao Lu; Xue-Xi Wang; Yan Wang; Yu-Jun Song; Xiao Wang; Munkhtuya Nyamgerelt
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

5.  Suppression of Breast Cancer Cell Migration by Small Interfering RNA Delivered by Polyethylenimine-Functionalized Graphene Oxide.

Authors:  Yuan-Pin Huang; Chao-Ming Hung; Yi-Chiang Hsu; Cai-Yan Zhong; Wan-Rou Wang; Chi-Chang Chang; Mon-Juan Lee
Journal:  Nanoscale Res Lett       Date:  2016-05-12       Impact factor: 4.703

Review 6.  Applications and toxicity of graphene family nanomaterials and their composites.

Authors:  Zorawar Singh
Journal:  Nanotechnol Sci Appl       Date:  2016-03-16

7.  Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo.

Authors:  Qi Sun; Xiaoli Wang; Chunying Cui; Jing Li; Yifan Wang
Journal:  Int J Nanomedicine       Date:  2018-06-27

8.  Anti-HER2 functionalized graphene oxide as survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo.

Authors:  Xiaoli Wang; Qi Sun; Chunying Cui; Jing Li; Yifan Wang
Journal:  Drug Des Devel Ther       Date:  2018-09-07       Impact factor: 4.162

Review 9.  Inhibition of regulated cell death by cell-penetrating peptides.

Authors:  Stefan Krautwald; Christin Dewitz; Fred Fändrich; Ulrich Kunzendorf
Journal:  Cell Mol Life Sci       Date:  2016-04-05       Impact factor: 9.261

10.  Preparation and Characterization of Functionalized Graphene Oxide Carrier for siRNA Delivery.

Authors:  Jing Li; Xu Ge; Chunying Cui; Yifan Zhang; Yifan Wang; Xiaoli Wang; Qi Sun
Journal:  Int J Mol Sci       Date:  2018-10-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.